Clinical Research

Found 104,753 articles

• 

  CDC: 14 Million Americans Will Have Alzheimer’s by 2060

  9/21/2018

  Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found. The U.S. Centers for Disease Control and Prevention published a new report in the journal Alzheimer’s & Dementia projecting the disease’s likely expansion, and for the firs...
• 

  Bay Area’s uBiome Secures $83 Million as It Moves into Drug Development, Taps ex-Novartis CEO for...

  9/21/2018

  San Francisco-based uBiome snagged $83 million in a Series C financing round and also tapped industry veteran Joe Jimenez, the former chief executive officer of Swiss pharma giant Novartis, to its board of directors.
• 

  September 21 Research Roundup: Zombie Cells, Pancreatic Cancer, Household Cleaners and Obesity, a...

  9/21/2018

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

• Global Fintech Leader Taps into Liberal Arts Creativity in Westerville, Ohio

  9/21/2018

  Otterbein University is leading an effort in the heart of Westerville to unite innovative research and development with a liberal arts approach to problem solving and education.

• Natural Nutritional Formula Offers Hope for People with Alzheimer's Disease

  9/21/2018

  A US-made capsule containing a unique combination of nutrients is being launched in New York, following a small, pilot study in Europe which showed that the supplement could benefit people with Alzheimer's Disease (AD), which is the sixth leading cause of death in the USA.

• SanBio: Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623

  9/21/2018

  SanBio Co., Ltd. hereby announces that it has resolved to enter into an equity and business alliances

• Diabetic Nephropathy - A Drug Pipeline Analysis Report by Technavio

  9/21/2018

  Technavio has announced their latest drug pipeline analysis report on diabetic nephropathy. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of diabetic nephropathy.

• LUNGevity to Present New Data from Its Patient Preference Study at 2018 World Conference on Lung Cancer

  9/21/2018

  LUNGevity's Project Transform captures what patients are seeking from their treatments

• LUNGevity to Present Two Studies from Its Patient FoRCe Research Center at the 2018 World Conference on Lung Cancer

  9/21/2018

  LUNGevity to present information about Attitudes Toward Re-Biopsy and a Patient Education Audit

• LUNGevity to Present Data from Study on Patient Empowerment at 2018 World Conference on Lung Cancer

  9/21/2018

  Study illuminates obstacles to patients receiving education about their disease

• Phosphorus Launches Expanded Dyslipidemia Test with Pharmacogenetic Indications and Polygenic Risk Score

  9/21/2018

  Phosphorus, a leader in diagnostic and bioinformatic solutions for clinical Next Generation Sequencing (NGS), announced today, at the National Lipid Association Fall Clinical Lipid Update meeting, the launch of an expanded genetic test for inherited dyslipidemias.

• Happiness and Aging - Seeking Answers to What's Right about Getting Older

  9/21/2018

  UCSD's Center for Healthy Aging resilience research centers on independent seniors

• 

  Molecular Templates and Takeda to Take on Multiple Myeloma in Deal Worth up to $632 Million

  9/20/2018

  Shares of Molecular Templates are up more than 52 percent in premarket trading after the company announced it has struck a deal with pharma giant Takeda Pharmaceuticals.

• New Study Demonstrates High Efficacy of HumanN's BeetElite for HIIT Training

  9/20/2018

  A new study on BeetElite, an endurance superfood from HumanN, has found that taking the product allows cycling participants to recover quicker between high intensity training intervals, and work out 17.9% longer.

• California Enacts First-In-Nation Law Requiring Doctors To Tell Patients When They Are On Probation, Says Consumer Watchdog

  9/20/2018

  Revelations by Women Sexually Assaulted By Their Doctors Spurred Transparency

• Invest in “Precision Health” to Better Care for High-Need, High-Cost Patients, AJMC® Researchers Say

  9/20/2018

  Any discussion involving “precision” in healthcare typically revolves around the use of precision medicine based on a patient’s genetic profile. However, in a commentary in the September issue of The American Journal of Managed Care®, authors Dhruv Khullar, MD, MPP, and Rainu Kaushal, MD, MPH, say there’s a different way that precision can be employed to better care for high-need, high-cost (HNHC) patients.

• New Research Finds Annual Well Visit Increases Likelihood of Preventive Services

  9/20/2018

  A new Harvey L. Neiman Health Policy Institute study assesses the effect of receiving an Annual Wellness Visit (AWV) between 2011 and 2013 on the annual rate of eight preventive services recommended for the Medicare population following the AWV. The study is published online in Preventive Medicine.

• American Enterprise Institute Report Confirms Nurse Practitioners are Vital to Solving America's Primary Care Access Crisis

  9/20/2018

  In a new report released by the American Enterprise Institute (AEI), health care economist and professor of nursing at Montana State University, Peter Buerhaus, finds nurse practitioners (NPs) to be a key solution to America's primary care crisis.

• Open Medicine Foundation Sponsors Second Annual Community Symposium on the Molecular Basis of ME/CFS at Stanford University

  9/20/2018

  pen Medicine Foundation (OMF), the premier nonprofit organization investing in research to cure myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), sponsors the Second Annual Community Symposium on the Molecular Basis of ME/CFS on September 29, 2018, at Stanford University.

• Study: Immediate Compression Could Help Prevent Complications After Deep-Vein Thrombosis

  9/20/2018

  People with deep-vein thrombosis (DVT) can substantially cut their risk of potentially debilitating complications by starting adequate compression therapy in the first twenty-four hours of DVT therapy (known as the acute phase of treatment), suggests a study published today in the journal Blood.